Sidestream cigarette smoke effects on cardiovascular responses in conscious rats: involvement of oxidative stress in the fourth cerebral ventricle
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
VALENTI, Vitor E.
ABREU, Luiz Carlos de
SATO, Monica A.
FERREIRA, Celso
ADAMI, Fernando
FONSECA, Fernando L. A.
XAVIER, Valdelias
GODOY, Moacir
MONTEIRO, Carlos B.
VANDERLEI, Luiz Carlos M.
Citação
BMC CARDIOVASCULAR DISORDERS, v.12, article ID 22, 13p, 2012
Resumo
Background: Cigarette exposure increases brain oxidative stress. The literature showed that increased brain oxidative stress affects cardiovascular regulation. However, no previous study investigated the involvement of brain oxidative stress in animals exposed to cigarette and its relationship with cardiovascular regulation. We aimed to evaluate the effects of central catalase inhibition on baroreflex and cardiovascular responses in rats exposed to sidestream cigarette smoke (SSCS). Methods: We evaluated males Wistar rats (320-370 g), which were implanted with a stainless steel guide cannula into the fourth cerebral ventricle (4th V). Femoral artery and vein were cannulated for mean arterial pressure (MAP) and heart rate (HR) measurement and drug infusion, respectively. Rats were exposed to SSCS during three weeks, 180 minutes, 5 days/week (CO: 100-300 ppm). Baroreflex was tested with a pressor dose of phenylephrine (PHE, 8 mu g/kg, bolus) to induce bradycardic reflex and a depressor dose of sodium nitroprusside (SNP, 50 mu g/kg, bolus) to induce tachycardic reflex. Cardiovascular responses were evaluated before, 5, 15, 30 and 60 minutes after 3-amino-1,2,4-triazole (ATZ, catalase inhibitor, 0.001 g/100 mu L) injection into the 4th V. Results: Central catalase inhibition increased basal HR in the control group during the first 5 minutes. SSCS exposure increased basal HR and attenuated bradycardic peak during the first 15 minutes. Conclusion: We suggest that SSCS exposure affects cardiovascular regulation through its influence on catalase activity.
Palavras-chave
Referências
- Bartoli CR, 2009, ENVIRON HEALTH PERSP, V117, P361, DOI 10.1289/ehp.11573
- Barutcu I, 2005, ANN NONINVAS ELECTRO, V10, P324, DOI 10.1111/j.1542-474X.2005.00636.x
- Bertagnolli M, 2006, J HYPERTENS, V24, P2437, DOI 10.1097/01.hjh.0000251905.08547.17
- Bonham AC, 2001, ENVIRON HEALTH PERSP, V109, P573, DOI 10.2307/3454672
- Brozoski DT, 2009, AUTON NEUROSCI-BASIC, V150, P82, DOI 10.1016/j.autneu.2009.05.243
- Cardoso LM, 2009, AM J PHYSIOL-REG I, V297, pR462, DOI 10.1152/ajpregu.90796.2008
- Cardoso LM, 2006, BRAIN RES BULL, V71, P37, DOI 10.1016/j.brainresbull.2006.07.013
- Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51
- Chu CP, 2005, NEUROSCI RES, V53, P147, DOI 10.1016/j.neures.2005.06.011
- Colombari E, 2001, HYPERTENSION, V38, P549
- CURVALL M, 1987, MUTAT RES, V188, P105, DOI 10.1016/0165-1218(87)90098-X
- Diethelm P, 2004, LANCET, V36, P4998
- Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327
- Farah VDA, 2007, CLINICS, V62, P477
- Gaemperli O, 2010, CURR PHARM DESIGN, V16, P2586
- Gao L, 2007, CIRCULATION, V115, P3095, DOI 10.1161/CIRCULATIONAHA.106.677989
- Gilmour M, 2006, ENVIRON HEALTH PERSP, V114, P627, DOI 10.1289/ehp.8380
- Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96
- HEAD GA, 1987, J AUTONOM NERV SYST, V21, P203, DOI 10.1016/0165-1838(87)90023-3
- Hirooka Y, 2008, AUTON NEUROSCI-BASIC, V142, P20, DOI 10.1016/j.autneu.2008.06.001
- Hirooka Y, 2011, HYPERTENS RES, V34, P407, DOI 10.1038/hr.2011.14
- Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2
- Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x
- Jin QH, 2003, BRAIN RES, V963, P224, DOI 10.1016/S0006-8993(02)03982-3
- Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001
- Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12
- Lee PN, 2001, INHAL TOXICOL, V13, P951, DOI 10.1080/089583701753210353
- Lopes H F, 2000, Arq Bras Cardiol, V75, P235
- Luchese C, 2009, PHARMACOL RES, V59, P194, DOI 10.1016/j.phrs.2008.11.006
- Ma LQ, 2011, J ALZHEIMERS DIS, V27, P225, DOI 10.3233/JAD-2011-110140
- MALAVEILLE C, 1989, CARCINOGENESIS, V10, P577, DOI 10.1093/carcin/10.3.577
- Mao LQ, 2002, ANAL CHEM, V74, P3684, DOI 10.1021/ac011261+
- Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108
- Paravicini TM, 2004, DRUGS, V64, P2143, DOI 10.2165/00003495-200464190-00001
- Pinheiro CHD, 2007, ARQ BRAS CARDIOL, V88, P651
- Prediger R.D., 2011, NEUROTOX RES
- Rickert WS, 2007, REGUL TOXICOL PHARM, V48, P320, DOI 10.1016/j.yrtph.2007.05.003
- ROCCHICCIOLI C, 1989, J CARDIOVASC PHARM, V14, P631, DOI 10.1097/00005344-198910000-00015
- Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288
- Talbot Prudence, 2008, Birth Defects Research, V84, P61, DOI 10.1002/bdrc.20120
- Valenti VE, 2011, J INTEGR NEUROSCI, V10, P161, DOI 10.1142/S0219635211002671
- Valenti VE, 2010, INT J ENVIRON HEAL R, V20, P431, DOI 10.1080/09603123.2010.491852
- Valenti VE, 2011, ARQ BRAS CARDIOL, V96, P148
- Valenti Vitor E, 2009, Arq Bras Cardiol, V92, P205
- Valenti VE, 2011, J INTEGR NEUROSCI, V10, P1, DOI 10.1142/S0219635211002580
- Varela-Carver Anabel, 2010, Curr Pharm Des, V16, P2551
- Wang G, 2004, J NEUROSCI, V24, P5516, DOI 10.1523/JNEUROSCI.1176-04.2004
- Wang Lei, 2007, Birth Defects Research, V81, P144, DOI 10.1002/bdrc.20097
- Zucker IH, 2006, HYPERTENSION, V48, P1005, DOI 10.1161/01.HYP.0000246614.47231.25